Your browser doesn't support javascript.
loading
Reply to the Letter to the Editor 'There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")' by W. Tjalma.
Sessa, C; Paluch-Shimon, S.
Affiliation
  • Sessa C; Medical Oncology, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • Paluch-Shimon S; Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel.
Ann Oncol ; 35(1): 139-140, 2024 Jan.
Article in En | MEDLINE | ID: mdl-37898238
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplastic Syndromes, Hereditary / Breast Neoplasms Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplastic Syndromes, Hereditary / Breast Neoplasms Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Suiza Country of publication: Reino Unido